Cargando…

GCT-37. PREVALENCE OF AUTISM SPECTRUM DISORDER AND OTHER NEURODEVELOPMENTAL DISORDERS IN PEDIATRIC PATIENTS WITH INTRACRANIAL GERM CELL TUMORS

PURPOSE/OBJECTIVE(S): Intracranial germ cell tumors (IGCTs) are rare tumors of the central nervous system with peak incidence around puberty. Due to the developmental origins of IGCTs, we investigated the prevalence of neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kevin X, Sethi, Roshan V, Pulsifer, Margaret B, D’Gama, Alissa M, Lavally, Beverly, Tarbell, Nancy J, Yock, Torunn I, MacDonald, Shannon M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Germ Cell Tumors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715171/ http://dx.doi.org/10.1093/neuonc/noaa222.256

Ejemplares similares

GCT-14. SECOND-LOOK SURGERY FOR INTRACRANIAL GERM CELL TUMORS
por: Ogiwara, Hideki
Publicado: (2020)

GCT-13. KRAS MUTATION IN PEDIATRIC INTRACRANIAL GERM CELL TUMORS
por: Khaiman, Chusana, et al.
Publicado: (2022)

GCT-61. CORRELATION OF PATTERNS OF DISEASE RECURRENCE WITH RADIOTHERAPY TECHNIQUES AND DOSE IN INTRACRANIAL GERM CELL TUMOURS (icGCT): LESSONS FROM THE UK COHORT OF SIOP GCT96 STUDY
por: Ajithkumar, Thankamma, et al.
Publicado: (2020)

GCT-31. DIAGNOSTIC CAPABILITY OF CSF-PLAP ON INTRACRANIAL GERM CELL TUMOR
por: Okamoto, Michinari, et al.
Publicado: (2020)

GCT-18. CLINICAL FEATURES OF GERM CELL TUMORS IN CHILDREN
por: Higa, Nayuta
Publicado: (2020)

GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020)

GCT-16. LONG-TERM CLINICAL OUTCOMES OF GERM CELL TUMORS
por: Matsuda, Kenichiro, et al.
Publicado: (2020)

GCT-34. ELUCIDATION OF THE MECHANISMS OF TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMOR BY WHOLE GENOME SEQUENCE
por: Yamagishi, Yuki, et al.
Publicado: (2020)

GCT-08. PROTON BEAM RADIOTHERAPY FOR PEDIATRIC AND YOUNG-ADULT PATIENTS WITH INTRACRANIAL GERM CELL TUMOR
por: Sugiyama, Minako, et al.
Publicado: (2020)

GCT-19. MODELING GERM CELL TUMORS WITH KIT MUTANT hiPSCs
por: Kuzuoka, Sakura, et al.
Publicado: (2020)

GCT-65. INCIDENCE AND OUTCOME OF INTRACRANIAL MALIGNANT GERM CELL TUMOURS DIAGNOSED IN WESTERN DENMARK IN THE LAST DECADE
por: Lassen-Ramshad, Yasmin, et al.
Publicado: (2020)

GCT-17. WHAT IS THE CLINICAL OUTCOME OF PROTON BEAM THERAPY FOR PATIENTS WITH INTRACRANIAL GERM CELL TUMOR IN KOREA?
por: Youn, Sang Hee, et al.
Publicado: (2020)

GCT-57. ARE MELATONIN LEVELS A RELIABLE MARKER FOR INTRACRANIAL GERM CELL TUMORS POST TREATMENT DEFICIENCY?
por: Cappellano, Andréa M, et al.
Publicado: (2020)

GCT-13. THE TREATMENT OUTCOMES OF INTRACRANIAL GERM CELL TUMORS WITH KSPNO PROTOCOL: SINGLE CENTER RETROSPECTIVE ANALYSIS
por: Go, Kyeong-O, et al.
Publicado: (2020)

GCT-09. HEALTH AND SOCIAL ISSUES IN THE LONG-TERM GERM-CELL TUMOR SURVIVORS
por: Matsutani, Tomoo, et al.
Publicado: (2020)

GCT-58. BRAZILIAN CENTRAL NERVOUS SYSTEM GERM CELL TUMOR CONSORTIUM PROTOCOL
por: Cappellano, Andréa M, et al.
Publicado: (2020)

GCT-60. DEVELOPMENT OF MICROBLEEDING AFTER PROTON THERAPY FOR PATIENTS WITH GERM CELL TUMOR
por: Kohzuki, Hidehiro, et al.
Publicado: (2020)

GCT-19. Toward understanding of the pathogenesis of central nervous system germ cell tumors
por: Ichimura, Koichi, et al.
Publicado: (2022)

GCT-46. MULTI-KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS AGAINST INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS
por: Uchida, Eita, et al.
Publicado: (2020)

GCT-29. DOES TUMOUR MARKER DECLINE PREDICT OUTCOME IN INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCTs)?
por: Conter, Cecile Faure, et al.
Publicado: (2020)

GCT-09. Transcriptome and methylome profiles of CNS germ cell tumors and their comparison with testicular counterpart
por: Takami, Hirokazu, et al.
Publicado: (2022)

GCT-12. SIOP CNS GCT II: High Risk (HR) CNS Non-germinomatous Germ Cell Tumours (NGGCT) treated with Dose intensified PEI – final results
por: Calaminus, Gabriele, et al.
Publicado: (2022)

GCT-28. RECURRENCE PATTERN AND SURVIVAL FOR RELAPSED INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A SINGLE-INSTITUTION EXPERIENCE
por: Wen, Lei, et al.
Publicado: (2020)

GCT-72. ANALYSIS OF microRNA EXPRESSION PROFILE OF INTRACRANIAL GERM CELL TUMORS: A PROMISING TOOL FOR DIFFERENTIAL DIAGNOSIS
por: Nakano, Yoshiko, et al.
Publicado: (2020)

GCT-30. TREATMENT OF PRIMARY INTRACRANIAL GERM CELL TUMORS: SINGLE INSTITUTION EXPERIENCE OF 74 CASES WITHOUT HISTOLOGICAL CONFIRMATION
por: Guo, Chengcheng, et al.
Publicado: (2020)

GCT-03. TREATMENT OUTCOMES, PHYSICAL DEVELOPMENT AND QUALITY OF LIFE OF PATIENTS WITH BIFOCAL GERM CELL TUMOURS
por: Li, Bo
Publicado: (2020)

GCT-70. INTRACRANIAL GROWING TERATOMA SYNDROME IN CHILDREN
por: Febres, Maria Carter, et al.
Publicado: (2020)

GCT-66. FINAL REPORT OF THE PROSPECTIVE NEXT/CNS-GCT-4 CONSORTIUM TRIAL (GemPOx FOLLOWED BY MARROW-ABLATIVE CHEMOTHERAPY) IN PATIENTS WITH REFRACTORY/RECURRENT CNS GERM CELL TUMORS
por: Shatara, Margaret, et al.
Publicado: (2020)

GCT-20. Multi-Institutional Analysis of Pediatric Relapsed/Refractory Central Nervous System Germ Cell Tumors
por: Nagabushan, Sumanth, et al.
Publicado: (2022)

GCT-73. EXPRESSION PROFILING OF INTRACRANIAL GERM CELL TUMORS REVEALS UPREGULATION OF RAS THROUGH mRNA-microRNA SIGNALING PATHWAY
por: Taylor, Aaron M, et al.
Publicado: (2020)

GCT-62. DISSECTING INTRATUMORAL HETEROGENEITY OF CENTRAL NERVOUS SYSTEM GERM CELL TUMORS BY SINGLE-CELL RNA-SEQUENCING
por: Nakano, Tomoyuki, et al.
Publicado: (2020)

GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
por: Oller, Agustina, et al.
Publicado: (2020)

GCT-67. CENTRAL NERVOUS SYSTEM GERMINOMA IN TWO CAUCASIAN AMERICAN SIBLINGS WITH AUTISM SPECTRUM DISORDER
por: Toll, Stephanie, et al.
Publicado: (2020)

GCT-40. PROGNOSTIC FACTORS FOR PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
por: Abu-Arja, Mohammad H, et al.
Publicado: (2020)

GCT-43. GAIN OF SHORT ARM OF CHROMOSOME 12 IS A MOLECULAR MARKER TO PREDICT PROGNOSIS AND REPRESENTS AN EARLY EVENT IN TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMORS
por: Satomi, Kaishi, et al.
Publicado: (2020)

GCT-20. EVALUATION OF NEURORADIOLOGICAL RESPONSE TO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH LOCALISED GERMINOMA IN THE SIOP CNS GCT II TRIAL
por: Bison, Brigitte, et al.
Publicado: (2020)

GCT-49. EVALUATION OF THE PERIOPERATIVE AND POSTOPERATIVE COURSE OF SURGERY OF PINEAL GERMINOMA ACCORDING TO THE SIOP CNS GCT 96 TRIAL
por: Shabo, Ehab, et al.
Publicado: (2020)

GCT-22. PROTEIN DEUBIQUITINATION PATHWAY IS A NOVEL THERAPEUTIC TARGET AGAINST MALIGNANT NON-GERMINOMATOUS CNS GERM CELL TUMORS
por: Tomiyama, Arata, et al.
Publicado: (2020)

GCT-74. RETROSPECTIVE LITERATURE REVIEW OF CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCTs) IN PATIENTS WITH DOWN SYNDROME (DS)
por: Harris, Micah K, et al.
Publicado: (2020)

GCT-75. ISOLATED PITUITARY STALK THICKENING
por: Bennett, Julie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h2hvm7d6qniqemfgigsvlh9qis